Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks [Yahoo! Finance]
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at Mizuho to a "hold" rating.
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last? [Yahoo! Finance]
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at Mizuho. They set a "neutral" rating and a $20.00 price target on the stock.
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025